BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Jung Hwan Lee, Sang Myung Woo, Eun Kyung Hong, Sang‐Jae Park, Sung‐Sik Han, Tae Hyun Kim, Ju Hee Lee, Woo Jin Lee. Cytopathological results of initial endoscopic ultrasound‐guided fine needle aspiration for primary mass and prognosis in pancreatic cancer patientsCytopathology 2019; 30(2): 173 doi: 10.1111/cyt.12675
2
Hayne Song, Jinhoi Song, Yeon Jeong Kim, Hyeon Hee Jeong, Hye Jin Min, Sang Seok Koh. DCPP1 is the mouse ortholog of human PAUF that possesses functional analogy in pancreatic cancerBiochemical and Biophysical Research Communications 2017; 493(4): 1498 doi: 10.1016/j.bbrc.2017.10.015
3
D. A. Gnatenko, E. P. Kopantsev, E. D. Sverdlov. The role of the signaling pathway FGF/FGFR in pancreatic cancerBiochemistry (Moscow), Supplement Series B: Biomedical Chemistry 2017; 11(2): 101 doi: 10.1134/S1990750817020032
4
Sirio Fiorino, Maria Letizia Bacchi-Reggiani, Chiara Birtolo, Giorgia Acquaviva, Michela Visani, Adele Fornelli, Michele Masetti, Andrea Tura, Stefano Sbrignadello, Fabio Grizzi, Federica Patrinicola, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Claudia Benini, Luca Di Tommaso, Arrigo Bondi, Francesco Monetti, Elena Siopis, Paolo Emilio Orlandi, Michele Imbriani, Carlo Fabbri, Silvia Giovanelli, Andrea Domanico, Esterita Accogli, Salomone Di Saverio, Daniela Grifoni, Vincenzo Cennamo, Paolo Leandri, Elio Jovine, Dario de Biase. Matricellular proteins and survival in patients with pancreatic cancer: A systematic reviewPancreatology 2018; 18(1): 122 doi: 10.1016/j.pan.2017.11.001
5
Magdalena Swierczewska, Serguei Kozlov, Pavan P. Adiseshaiah. Oncogenomics2019; : 313 doi: 10.1016/B978-0-12-811785-9.00022-3
6
Bing Ren, Xiaoying Liu, Arief A. Suriawinata. Pancreatic Ductal Adenocarcinoma and Its Precursor LesionsThe American Journal of Pathology 2019; 189(1): 9 doi: 10.1016/j.ajpath.2018.10.004
7
Anna De Blasio, Renza Vento, Riccardo Di Fiore. Mcl-1 targeting could be an intriguing perspective to cure cancerJournal of Cellular Physiology 2018; 233(11): 8482 doi: 10.1002/jcp.26786
8
Keiichi Yonemori, Naohiko Seki, Hiroshi Kurahara, Yusaku Osako, Tetsuya Idichi, Takayuki Arai, Keiichi Koshizuka, Yoshiaki Kita, Kosei Maemura, Shoji Natsugoe. ZFP36L2promotes cancer cell aggressiveness and is regulated by antitumormicroRNA-375in pancreatic ductal adenocarcinomaCancer Science 2017; 108(1): 124 doi: 10.1111/cas.13119
9
Srinivasa P. Pothula, Zhihong Xu, David Goldstein, Romano C. Pirola, Jeremy S. Wilson, Minoti V. Apte. Key role of pancreatic stellate cells in pancreatic cancerCancer Letters 2016; 381(1): 194 doi: 10.1016/j.canlet.2015.10.035
10
Tianjiao Li, Hao Li, Shuo Li, Shuaishuai Xu, Wuhu Zhang, Heli Gao, Huaxiang Xu, Chuntao Wu, Wenquan Wang, Xianjun Yu, Liang Liu. Research progress and design optimization of CAR‐T therapy for pancreatic ductal adenocarcinomaCancer Medicine 2019; 8(11): 5223 doi: 10.1002/cam4.2430
11
Yuanyuan Pei, Liang Chen, Yukun Huang, Jiahao Wang, Jingxian Feng, Minjun Xu, Yu Chen, Qingxiang Song, Gan Jiang, Xiao Gu, Qian Zhang, Xiaoling Gao, Jun Chen. Sequential Targeting TGF‐β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic CancerSmall 2019; 15(24): 1900631 doi: 10.1002/smll.201900631
12
Wenzel M. Hackeng, Ralph H. Hruban, G. Johan A. Offerhaus, Lodewijk A. A. Brosens. Surgical and molecular pathology of pancreatic neoplasmsDiagnostic Pathology 2016; 11(1) doi: 10.1186/s13000-016-0497-z
13
Shigeo Koido, Masato Okamoto, Shigetaka Shimodaira, Haruo Sugiyama. Wilms’ tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancerImmunotherapy 2016; 8(11): 1309 doi: 10.2217/imt-2016-0031
14
Sadaf Ghanaatgar-Kasbi, Shadi Khorrami, Amir Avan, Seyed A. Aledavoud, Gordon A. Ferns. Targeting the C-MET/HGF Signaling Pathway in Pancreatic Ductal AdenocarcinomaCurrent Pharmaceutical Design 2019; 24(39): 4619 doi: 10.2174/1381612825666190110145855
15
Aleksandra Adamska, Alice Domenichini, Emily Capone, Verena Damiani, Begum Gokcen Akkaya, Kenneth J. Linton, Pierluigi Di Sebastiano, Xi Chen, Adam B. Keeton, Veronica Ramirez-Alcantara, Yulia Maxuitenko, Gary A. Piazza, Vincenzo De Laurenzi, Gianluca Sala, Marco Falasca. Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancerJournal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1308-7
16
Chung-Tzu Hsueh, Julie H Selim, James Y Tsai, Chung-Tsen Hsueh. Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinomaWorld Journal of Gastroenterology 2016; 22(31): 7080-7090 doi: 10.3748/wjg.v22.i31.7080
17
Ryo Takaji, Yasunari Yamada, Shunro Matsumoto, Maki Kiyonaga, Norio Hongo, Hiromu Mori, Naoki Hijiya, Masayuki Ohta, Masafumi Inomata, Hajime Takaki, Kengo Fukuzawa, Hirotoshi Yonemasu. Small pancreatic ductal carcinomas on triple-phase contrast-enhanced computed tomography: enhanced rims and the pathologic correlationAbdominal Radiology 2018; 43(12): 3374 doi: 10.1007/s00261-018-1645-6
18
Daniel Ansari, Adam Gustafsson, Roland Andersson. Update on the management of pancreatic cancer: Surgery is not enoughWorld Journal of Gastroenterology 2015; 21(11): 3157-3165 doi: 10.3748/wjg.v21.i11.3157
19
Milind Javle, Talia Golan, Anirban Maitra. Changing the course of pancreatic cancer – Focus on recent translational advancesCancer Treatment Reviews 2016; 44: 17 doi: 10.1016/j.ctrv.2016.01.004
20
Aleksandra Adamska, Alice Domenichini, Marco Falasca. Pancreatic Ductal Adenocarcinoma: Current and Evolving TherapiesInternational Journal of Molecular Sciences 2017; 18(7): 1338 doi: 10.3390/ijms18071338
21
Myrna Hurtado, Umesh T. Sankpal, Amalendu Ranjan, Rajasekhar Maram, Jamboor K. Vishwanatha, Ganji Purnachandra Nagaraju, Bassel F. El-Rayes, Riyaz Basha. Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancerCritical Reviews in Oncology/Hematology 2018; 126: 201 doi: 10.1016/j.critrevonc.2018.03.016
22
Archana Bhaw-Luximon, Dhanjay Jhurry. New avenues for improving pancreatic ductal adenocarcinoma (PDAC) treatment: Selective stroma depletion combined with nano drug deliveryCancer Letters 2015; 369(2): 266 doi: 10.1016/j.canlet.2015.09.007
23
Melek Karaca, Rinku Dutta, Yildiz Ozsoy, Ram I. Mahato. Micelle Mixtures for Coadministration of Gemcitabine and GDC-0449 To Treat Pancreatic CancerMolecular Pharmaceutics 2016; 13(6): 1822 doi: 10.1021/acs.molpharmaceut.5b00971
24
Aoife S Crawley, Richard J O’Kennedy. The need for effective pancreatic cancer detection and management: a biomarker-based strategyExpert Review of Molecular Diagnostics 2015; 15(10): 1339 doi: 10.1586/14737159.2015.1083862
25
Dai Hoon Han, Chang Moo Kang, Sung Whan Lee, Ho Kyoung Hwang, Woo Jung Lee. A missing link between RON expression and oncological outcomes in resected left-sided pancreatic cancerOncology Letters 2017; 14(4): 4225 doi: 10.3892/ol.2017.6696
26
Rachel L. O. Olson, Judith V. Forner, Pilar Navarro, Martin E. Fernandez-Zapico, Ahmed M. Elamir. Pancreatic Cancer2018; : 1 doi: 10.1007/978-1-4939-6631-8_89-1
27
Craig D. Logsdon, Thiruvengadam Arumugam, Vijaya Ramachandran. Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeuticsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2015; 309(5): G283 doi: 10.1152/ajpgi.00169.2015
28
Rachel L. O. Olson, Judith V. Forner, Pilar Navarro, Martin E. Fernandez-Zapico, Ahmed M. Elamir. Pancreatic Cancer2018; : 539 doi: 10.1007/978-1-4939-7193-0_89
29
Srinivasa P Pothula, Zhihong Xu, David Goldstein, Andrew V Biankin, Romano C Pirola, Jeremy S Wilson, Minoti V Apte. Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancerBritish Journal of Cancer 2016; 114(3): 269 doi: 10.1038/bjc.2015.478
30
Naofumi Mukaida, Soichiro Sasaki. Fibroblasts, an inconspicuous but essential player in colon cancer development and progressionWorld Journal of Gastroenterology 2016; 22(23): 5301-5316 doi: 10.3748/wjg.v22.i23.5301
31
Stefano Coppola, Ilaria Carnevale, Erik H.J. Danen, Godefridus J. Peters, Thomas Schmidt, Yehuda G. Assaraf, Elisa Giovannetti. A mechanopharmacology approach to overcome chemoresistance in pancreatic cancerDrug Resistance Updates 2017; 31: 43 doi: 10.1016/j.drup.2017.07.001
32
Laleh G. Melstrom, Marcela D. Salazar, Don J. Diamond. The pancreatic cancer microenvironment: A true double agentJournal of Surgical Oncology 2017; 116(1): 7 doi: 10.1002/jso.24643
33
Osama Al-Assar, Martin-Immanuel Bittner, Serena Lunardi, Michael R. Stratford, W. Gillies McKenna, Thomas B. Brunner. The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cellsRadiotherapy and Oncology 2016; 119(2): 300 doi: 10.1016/j.radonc.2016.03.024
34
Joni Leppänen, Ville Lindholm, Joel Isohookana, Kirsi-Maria Haapasaari, Peeter Karihtala, Petri P. Lehenkari, Juha Saarnio, Joonas H. Kauppila, Tuomo J. Karttunen, Olli Helminen, Heikki Huhta. Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal AdenocarcinomaPancreas 2019; 48(1): 43 doi: 10.1097/MPA.0000000000001195
35
Kelly J. Lafaro, Laleh G. Melstrom. The Paradoxical Web of Pancreatic Cancer Tumor MicroenvironmentThe American Journal of Pathology 2019; 189(1): 44 doi: 10.1016/j.ajpath.2018.09.009
36
Xiaohong Li, Ying Xiao, Shaoqing Fan, Mingbing Xiao, Xiaotong Wang, Xiaolin Zhu, Xudong Chen, Chunsun Li, Guijuan Zong, Guoxiong Zhou, Chunhua Wan. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinomaHuman Pathology 2016; 57: 182 doi: 10.1016/j.humpath.2016.07.015
37
V. Taucher, Johannes Haybaeck. Mechanisms of Molecular Carcinogenesis – Volume 22017; : 83 doi: 10.1007/978-3-319-53661-3_5
38
Marco Falasca, Minkyoung Kim, Ilaria Casari. Pancreatic cancer: Current research and future directionsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2016; 1865(2): 123 doi: 10.1016/j.bbcan.2016.01.001
39
Janaiah Kota, Julie Hancock, Jason Kwon, Murray Korc. Pancreatic cancer: Stroma and its current and emerging targeted therapiesCancer Letters 2017; 391: 38 doi: 10.1016/j.canlet.2016.12.035
40
Shin Il Kim, Jun Young Shin, Jin-Seok Park, Seok Jeong, Yong Sun Jeon, Moon Han Choi, Hyun Jong Choi, Jong Ho Moon, Jae Chul Hwang, Min Jae Yang, Byoung Moo Yoo, Jin Hong Kim, Hyun Woo Lee, Chang-Il Kwon, Don Haeng Lee. Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic cancerPancreatology 2017; 17(1): 103 doi: 10.1016/j.pan.2016.10.008
41
B. Čunderlíková. Clinical significance of immunohistochemically detected extracellular matrix proteins and their spatial distribution in primary cancerCritical Reviews in Oncology/Hematology 2016; 105: 127 doi: 10.1016/j.critrevonc.2016.04.017
42
Huan Meng, Andre E. Nel. Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancerAdvanced Drug Delivery Reviews 2018; 130: 50 doi: 10.1016/j.addr.2018.06.014
43
Chang Liu, Jin-Ou Wang, Wen-Yang Zhou, Xiao-Ying Chang, Ming-Ming Zhang, Ying Zhang, Xiang-Hong Yang. Long non-coding RNA LINC01207 silencing suppresses AGR2 expression to facilitate autophagy and apoptosis of pancreatic cancer cells by sponging miR-143-5pMolecular and Cellular Endocrinology 2019; 493: 110424 doi: 10.1016/j.mce.2019.04.004
44
Yang Liu, Lianfang Du. Role of pancreatic stellate cells and periostin in pancreatic cancer progressionTumor Biology 2015; 36(5): 3171 doi: 10.1007/s13277-015-3386-2
45
Miriam Klau, Philipp Mayer, Frank Bergmann, Klaus Maier-Hein, Judith Hase, Thilo Hackert, Hans-Ulrich Kauczor, Lars Grenacher, Bram Stieltjes. Correlation of Histological Vessel Characteristics and Diffusion-Weighted Imaging Intravoxel Incoherent Motion–Derived Parameters in Pancreatic Ductal Adenocarcinomas and Pancreatic Neuroendocrine TumorsInvestigative Radiology 2015; 50(11): 792 doi: 10.1097/RLI.0000000000000187
46
A K Thakur, J Nigri, S Lac, J Leca, C Bressy, P Berthezene, L Bartholin, P Chan, E Calvo, J L Iovanna, S Vasseur, F Guillaumond, R Tomasini. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinomaCell Death & Differentiation 2016; 23(8): 1358 doi: 10.1038/cdd.2016.18
47
Zipeng Lu, Maximilian Weniger, Kuirong Jiang, Stefan Boeck, Kai Zhang, Alexander Bazhin, Yi Miao, Jens Werner, Jan G. D’Haese. Therapies Targeting the Tumor Stroma and the VEGF/VEGFR Axis in Pancreatic Ductal Adenocarcinoma: a Systematic Review and Meta-AnalysisTargeted Oncology 2018; 13(4): 447 doi: 10.1007/s11523-018-0578-x
48
Xianbin Zhang, Maria Schönrogge, Johanna Eichberg, Edgar Heinz Uwe Wendt, Simone Kumstel, Jan Stenzel, Tobias Lindner, Robert Jaster, Bernd Joachim Krause, Brigitte Vollmar, Dietmar Zechner. Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer CellsFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00590
49
Jin Long, Zhe Liu, Lian Hui. Anti-tumor effect and mechanistic study of elemene on pancreatic carcinomaBMC Complementary and Alternative Medicine 2019; 19(1) doi: 10.1186/s12906-019-2544-2
50
Marc Damelin. Innovations for Next-Generation Antibody-Drug ConjugatesCancer Drug Discovery and Development 2018; : 1 doi: 10.1007/978-3-319-78154-9_1